Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile
Sak Chirapongsathorn, M.D.

@sakkarinc

Associate professor of Gastroenterology. Liver specialist | Research interests in MASLD and ACLF | Living in Bangkok | Tweets are mine.

ID: 130167283

calendar_today06-04-2010 14:25:56

700 Tweet

371 Followers

609 Following

Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

AUD is highly prevalent after bariatric surgery, with rising cases of ARLD in this population. Patients with ARLD post-bariatric surgery have poorer outcomes. #SLDSummit EASLnews

AUD is highly prevalent after bariatric surgery, with rising cases of ARLD in this population. Patients with ARLD post-bariatric surgery have poorer outcomes. #SLDSummit 
<a href="/EASLnews/">EASLnews</a>
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Great news‼️Our MASLD team has 9⃣ abstract submissions accepted for #DDW2025! Excited to present 3 as Lecture Presentations. Grateful to work with such an incredible team! See you in San Diego!⭐ #GIPMK #DDW2025 Digestive Disease Week

Great news‼️Our MASLD team has 9⃣ abstract submissions accepted for #DDW2025! Excited to present 3 as Lecture Presentations. Grateful to work with such an incredible team! See you in San Diego!⭐

#GIPMK
#DDW2025
<a href="/DDWMeeting/">Digestive Disease Week</a>
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Multidisciplinary team (MDT) involvement in liver cancer treatment is beneficial, but it can sometimes introduce bias. #LiverCancerSummit EASLnews

Multidisciplinary team (MDT) involvement in liver cancer treatment is beneficial, but it can sometimes introduce bias. 
#LiverCancerSummit 
<a href="/EASLnews/">EASLnews</a>
Daniel Huang (@drhuangdq) 's Twitter Profile Photo

Enjoyed speaking on MASLD and alcohol-associated liver disease in Bangkok at the PMK meeting and Grand rounds Thanks Sak Chirapongsathorn, M.D. for the kind invitation and great to meet many brilliant and passionate young GIs from 🇹🇭 💪

Enjoyed speaking on MASLD and alcohol-associated liver disease in Bangkok at the PMK meeting and Grand rounds

Thanks <a href="/SakkarinC/">Sak Chirapongsathorn, M.D.</a> for the kind invitation and great to meet many brilliant and passionate young GIs from 🇹🇭 💪
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

I am honored to visit Hangzhou Xixi Hospital and Zhejiang University. Thank you, Prof. Jin Xiaofai and Prof. Bill Lin, for your kind invitation and hospitality. Look forward to future research collaboration.

I am honored to visit Hangzhou Xixi Hospital and Zhejiang University. Thank you, Prof. Jin Xiaofai and Prof. Bill Lin, for your kind invitation and hospitality. Look forward to future research collaboration.
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Completed 3 talks at APASL 2025 Beijing and joined meaningful meetings alongside. Sadly, the event was marked by the earthquake in Thailand 😢 — my thoughts are with everyone affected. Now ready to head back home. Wishing safety and strength to all 🇹🇭. #apasl2025

Completed 3 talks at APASL 2025 Beijing and joined meaningful meetings alongside. Sadly, the event was marked by the earthquake in Thailand  😢 — my thoughts are with everyone affected. Now ready to head back home. Wishing safety and strength to all 🇹🇭. #apasl2025
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

We would like to thank Professor Amit G. Singal from the University of Texas Southwestern, USA, for visiting us today. It was a great opportunity to learn from an expert. 🇹🇭 🇺🇸#GIPMK

We would like to thank Professor Amit G. Singal from the University of Texas Southwestern, USA, for visiting us today. It was a great opportunity to learn from an expert.
🇹🇭 🇺🇸#GIPMK
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Join me in person or online at #DDW2025 to get the latest advancements in the digestive disease field. Register today to hear my presentation at app.ingo.me/q/rjlln .

Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Semaglutide in MASH: Phase 3 ESSENCE trial just dropped! ✅ 63% achieved MASH resolution (vs. 34% placebo) in 72 wks ✅36% had fibrosis improvement (vs. 22%) in 72 wks ✅Avg. weight loss: −10.5% (vs. −2%) Full text: nejm.org/doi/full/10.10… #MASLD #MASH #ESSENCE

Semaglutide in MASH: Phase 3 ESSENCE trial just dropped!
✅ 63% achieved MASH resolution (vs. 34% placebo) in 72 wks
✅36% had fibrosis improvement (vs. 22%) in 72 wks
✅Avg. weight loss: −10.5% (vs. −2%)

Full text: nejm.org/doi/full/10.10…

#MASLD
#MASH
#ESSENCE
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Proud to share that our team will present 9 presentations at DDW 2025 this year! A big thank you to everyone in our team for their dedication and hard work. Looking forward to an inspiring and collaborative experience at #DDW2025. #GIPMK

Proud to share that our team will present 9 presentations at DDW 2025 this year! A big thank you to everyone in our team for their dedication and hard work. Looking forward to an inspiring and collaborative experience at #DDW2025.
#GIPMK
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

Honored to be invited to give a talk in Da Nang, Vietnam on MASLD and MetALD in Metabolic Council Conference 2025. It was a great opportunity to exchange knowledge and insights with leading experts in the field. Grateful for the warm welcome and meaningful discussions. #GIPMK

Honored to be invited to give a talk in Da Nang, Vietnam on MASLD and MetALD in Metabolic Council Conference 2025.
It was a great opportunity to exchange knowledge and insights with leading experts in the field.
Grateful for the warm welcome and meaningful discussions. 

#GIPMK
Sak Chirapongsathorn, M.D. (@sakkarinc) 's Twitter Profile Photo

I am honored to speak on MASLD/ MASH at the Japan Atherosclerosis Society's conference. I’m truly humbled to share the stage with two legends and giants in the field, Professor Atsushi Nakajima and APASL President Professor Lai Wei. Thank you for kind invitation. #GIPMK

I am honored to speak on MASLD/ MASH at the Japan Atherosclerosis Society's conference. I’m truly humbled to share the stage with two legends and giants in the field, Professor Atsushi Nakajima and APASL President Professor Lai Wei. 
Thank you for kind invitation.
#GIPMK